Literature DB >> 33129055

Tumor microenvironment and Oral Squamous Cell Carcinoma: A crosstalk between the inflammatory state and tumor cell migration.

Alessandro Alves1, Leonardo Diel2, Grasieli Ramos3, Antônio Pinto4, Lisiane Bernardi5, John Yates6, Marcelo Lamers7.   

Abstract

OBJECTIVES: To analyze the inflammatory millieu in oral squamous cell carcinoma (OSCC) tumors and the influence of macrophages related-cytokines on the tumor cell migration.
MATERIALS AND METHODS: Inflammatory protein profile and macrophage population (M2/M1 ratio) of human OSCC fragments were analyzed by proteomic analysis and flow cytometry assay respectively. To evaluate the effects of inflammation on OSCC behavior, we analyzed the role of polarized macrophages and cytokines (IL-6, IL-1β and TNF-α) on OSCC cell lines (SCC25 and Cal27) responsiveness by western blotting (cell signaling) and time-lapse (cell migration). Also, it was addressed the crosstalk of IL-6-STAT3 axis with cell migration signaling using a STAT3 inhibitor (Stattic®) and a pull down assay for the RhoGTPase Rac1 activity.
RESULTS: It was observed a ~2 fold predominance of M2 over M1 macrophages and a pro-inflammatory state in OSCC fragments. The M2 conditioned media increased migration speed and directionality of highly invasive OSCC cells (SCC25). OSCC cell lines were responsive to cytokine stimuli (IL6, IL-1β and TNF-α), but only IL-6 increased migration properties of OSCC cells. This effect was dependent on STAT3-phosphorylation levels, which interfered with Rac1 activation levels.
CONCLUSION: Our results suggest that the inflammatory milieu might favor invasion and metastasis of OSCC by the direct effect of macrophage-related cytokines on tumor migration.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell migration; IL-6; Interleukins; Oral cancer; Rho GTPases

Year:  2020        PMID: 33129055     DOI: 10.1016/j.oraloncology.2020.105038

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  8 in total

1.  Prognostic and clinicopathological significance of tumor-stroma ratio in head and neck squamous cell carcinoma: A systematic review.

Authors:  E-F Morais; H-G Morais; H-D Martins; L-M Carlan; A-D Costa; R-D Freitas
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2022-07-01

Review 2.  Rac1 as a Target to Treat Dysfunctions and Cancer of the Bladder.

Authors:  Vincent Sauzeau; Julien Beignet; Christian Bailly
Journal:  Biomedicines       Date:  2022-06-08

3.  M1-like tumor-associated macrophages cascade a mesenchymal/stem-like phenotype of oral squamous cell carcinoma via the IL6/Stat3/THBS1 feedback loop.

Authors:  Yuanhe You; Zhuowei Tian; Zhong Du; Kailiu Wu; Guisong Xu; Meilu Dai; Yan'an Wang; Meng Xiao
Journal:  J Exp Clin Cancer Res       Date:  2022-01-06

4.  Crosstalk between cancer and different cancer stroma subtypes promotes the infiltration of tumor‑associated macrophages into the tumor microenvironment of oral squamous cell carcinoma.

Authors:  Qiusheng Shan; Kiyofumi Takabatake; Hotaka Kawai; May Wathone Oo; Shintaro Sukegawa; Masae Fujii; Keisuke Nakano; Hitoshi Nagatsuka
Journal:  Int J Oncol       Date:  2022-05-06       Impact factor: 5.884

Review 5.  The role of tumor-associated macrophages in oral squamous cell carcinoma.

Authors:  Yiwen Xue; Xiao Song; Siyu Fan; Runzhi Deng
Journal:  Front Physiol       Date:  2022-08-29       Impact factor: 4.755

6.  A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.

Authors:  Yun Chen; Yunzhi Feng; Fei Yan; Yaqiong Zhao; Han Zhao; Yue Guo
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

Review 7.  STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma.

Authors:  Mingjing Jiang; Bo Li
Journal:  Cells       Date:  2022-10-05       Impact factor: 7.666

8.  Tongue Cancer Cell-Derived CCL20 Induced by Interaction With Macrophages Promotes CD163 Expression on Macrophages.

Authors:  Manabu Shigeoka; Yu-Ichiro Koma; Takayuki Kodama; Mari Nishio; Masaya Akashi; Hiroshi Yokozaki
Journal:  Front Oncol       Date:  2021-06-09       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.